PharmiWeb.com - Global Pharma News & Resources

Berlin Cures

Research & Development

Berlin Cures Holding AG is a spin-off company founded in September 2014 in order to bring a successful research project to the market. A group of scientists from the Max Delbrück Center (MDC), the Charité Berlin and the German Heart Institute Berlin has been studying the significance of autoantibodies in heart disease and other autoimmune diseases for over 10 years.